219 related articles for article (PubMed ID: 36211427)
1. Process development and preclinical evaluation of a major
Somanathan A; Mian SY; Chaddha K; Uchoi S; Bharti PK; Tandon R; Gaur D; Chauhan VS
Front Immunol; 2022; 13():1005332. PubMed ID: 36211427
[No Abstract] [Full Text] [Related]
2. Plasmodium falciparum Cysteine-Rich Protective Antigen (CyRPA) Elicits Detectable Levels of Invasion-Inhibitory Antibodies during Natural Infection in Humans.
Mian SY; Somanathan A; Chaddha K; Pandey AK; Singh H; Krishna S; Chaturvedi N; Uchoi S; Shukla MM; Bharti PK; Singh N; Chauhan VS; Gaur D
Infect Immun; 2022 Jan; 90(1):e0037721. PubMed ID: 34694918
[TBL] [Abstract][Full Text] [Related]
3. RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting.
Healer J; Thompson JK; Mackwell KL; Browne CD; Seager BA; Ngo A; Lowes KN; Silk SE; Pulido D; King LDW; Christen JM; Noe AR; Kotraiah V; Masendycz PJ; Rajagopalan R; Lucas L; Stanford MM; Soisson L; Diggs C; Miller R; Youll S; Wycherley K; Draper SJ; Cowman AF
Front Cell Infect Microbiol; 2022; 12():1049065. PubMed ID: 36605129
[TBL] [Abstract][Full Text] [Related]
4. Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen.
Dreyer AM; Matile H; Papastogiannidis P; Kamber J; Favuzza P; Voss TS; Wittlin S; Pluschke G
J Immunol; 2012 Jun; 188(12):6225-37. PubMed ID: 22593616
[TBL] [Abstract][Full Text] [Related]
5. Multiprotein complex between the GPI-anchored CyRPA with PfRH5 and PfRipr is crucial for Plasmodium falciparum erythrocyte invasion.
Reddy KS; Amlabu E; Pandey AK; Mitra P; Chauhan VS; Gaur D
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1179-84. PubMed ID: 25583518
[TBL] [Abstract][Full Text] [Related]
6. Antibody Combinations Targeting the Essential Antigens CyRPA, RH5, and MSP-119 Potently Neutralize Plasmodium falciparum Clinical Isolates From India and Africa.
Singh H; Mian SY; Pandey AK; Krishna S; Anand G; Reddy KS; Chaturvedi N; Bahl V; Hans N; Shukla MM; Bassat Q; Mayor A; Miura K; Bharti PK; Long C; Singh N; Chauhan VS; Gaur D
J Infect Dis; 2021 Jun; 223(11):1953-1964. PubMed ID: 32989463
[TBL] [Abstract][Full Text] [Related]
7. Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA.
Favuzza P; Blaser S; Dreyer AM; Riccio G; Tamborrini M; Thoma R; Matile H; Pluschke G
Malar J; 2016 Mar; 15():161. PubMed ID: 26979066
[TBL] [Abstract][Full Text] [Related]
8. Functional Comparison of Blood-Stage
Illingworth JJ; Alanine DG; Brown R; Marshall JM; Bartlett HE; Silk SE; Labbé GM; Quinkert D; Cho JS; Wendler JP; Pattinson DJ; Barfod L; Douglas AD; Shea MW; Wright KE; de Cassan SC; Higgins MK; Draper SJ
Front Immunol; 2019; 10():1254. PubMed ID: 31214195
[TBL] [Abstract][Full Text] [Related]
9. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies.
Reddy KS; Pandey AK; Singh H; Sahar T; Emmanuel A; Chitnis CE; Chauhan VS; Gaur D
Infect Immun; 2014 Jan; 82(1):152-64. PubMed ID: 24126527
[TBL] [Abstract][Full Text] [Related]
10. Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies.
Pandey AK; Reddy KS; Sahar T; Gupta S; Singh H; Reddy EJ; Asad M; Siddiqui FA; Gupta P; Singh B; More KR; Mohmmed A; Chitnis CE; Chauhan VS; Gaur D
Infect Immun; 2013 Feb; 81(2):441-51. PubMed ID: 23184525
[TBL] [Abstract][Full Text] [Related]
11. Strain-Dependent Inhibition of Erythrocyte Invasion by Monoclonal Antibodies Against
Knudsen AS; Björnsson KH; Bassi MR; Walker MR; Kok A; Cristinoi B; Jensen AR; Barfod L
Front Immunol; 2021; 12():716305. PubMed ID: 34447381
[TBL] [Abstract][Full Text] [Related]
12. The Structure of the Cysteine-Rich Domain of Plasmodium falciparum P113 Identifies the Location of the RH5 Binding Site.
Campeotto I; Galaway F; Mehmood S; Barfod LK; Quinkert D; Kotraiah V; Phares TW; Wright KE; Snijders AP; Draper SJ; Higgins MK; Wright GJ
mBio; 2020 Sep; 11(5):. PubMed ID: 32900802
[No Abstract] [Full Text] [Related]
13. Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex.
Williams BG; King LDW; Pulido D; Quinkert D; Lias AM; Silk SE; Ragotte RJ; Davies H; Barrett JR; McHugh K; Rigby CA; Alanine DGW; Barfod L; Shea MW; Cowley LA; Dabbs RA; Pattinson DJ; Douglas AD; Lyth OR; Illingworth JJ; Jin J; Carnrot C; Kotraiah V; Christen JM; Noe AR; MacGill RS; King CR; Birkett AJ; Soisson LA; Skinner K; Miura K; Long CA; Higgins MK; Draper SJ
Nat Commun; 2024 Jun; 15(1):4857. PubMed ID: 38849365
[TBL] [Abstract][Full Text] [Related]
14. Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations.
Azasi Y; Gallagher SK; Diouf A; Dabbs RA; Jin J; Mian SY; Narum DL; Long CA; Gaur D; Draper SJ; Fay MP; Miller LH; Miura K
Sci Rep; 2020 Jul; 10(1):11802. PubMed ID: 32678144
[TBL] [Abstract][Full Text] [Related]
15. The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target.
Ragotte RJ; Higgins MK; Draper SJ
Trends Parasitol; 2020 Jun; 36(6):545-559. PubMed ID: 32359873
[TBL] [Abstract][Full Text] [Related]
16. Identification and Immune Assessment of T Cell Epitopes in Five
Kotraiah V; Phares TW; Terry FE; Hindocha P; Silk SE; Nielsen CM; Moise L; Tucker KD; Ashfield R; Martin WD; De Groot AS; Draper SJ; Gutierrez GM; Noe AR
Front Immunol; 2021; 12():690348. PubMed ID: 34305923
[TBL] [Abstract][Full Text] [Related]
17. The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.
de Silva HD; Saleh S; Kovacevic S; Wang L; Black CG; Plebanski M; Coppel RL
Malar J; 2011 Sep; 10():266. PubMed ID: 21920045
[TBL] [Abstract][Full Text] [Related]
18. Strain-transcending neutralization of malaria parasite by antibodies against Plasmodium falciparum enolase.
Dutta S; Tewari A; Balaji C; Verma R; Moitra A; Yadav M; Agrawal P; Sahal D; Jarori GK
Malar J; 2018 Aug; 17(1):304. PubMed ID: 30126436
[TBL] [Abstract][Full Text] [Related]
19. A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein.
Ord RL; Caldeira JC; Rodriguez M; Noe A; Chackerian B; Peabody DS; Gutierrez G; Lobo CA
Malar J; 2014 Aug; 13():326. PubMed ID: 25135070
[TBL] [Abstract][Full Text] [Related]
20. Structure of Plasmodium falciparum Rh5-CyRPA-Ripr invasion complex.
Wong W; Huang R; Menant S; Hong C; Sandow JJ; Birkinshaw RW; Healer J; Hodder AN; Kanjee U; Tonkin CJ; Heckmann D; Soroka V; Søgaard TMM; Jørgensen T; Duraisingh MT; Czabotar PE; de Jongh WA; Tham WH; Webb AI; Yu Z; Cowman AF
Nature; 2019 Jan; 565(7737):118-121. PubMed ID: 30542156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]